Comparison of Video Consent Versus Routine Consent for Participation in Research Studies
NCT ID: NCT00430391
Last Updated: 2013-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
382 participants
INTERVENTIONAL
2003-12-31
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Memantine Augmentation of Targeted Cognitive Training in Schizophrenia
NCT04857983
Enhancing Comprehension of Consent in Patients With Psychotic Disorders
NCT06975670
Financial Incentives to Improve Acceptance of Antipsychotic Injections
NCT03192631
Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients
NCT00097942
Sensorimotor Gating in Schizophrenia
NCT00561561
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants with schizophrenia and a normal comparison group will participate in either a routinely used informed consent procedure or an enhanced, DVD-based informed consent procedure. The outcome measure, comprehension of the consent materials, including understanding of the risks and benefits of participating in the study, will be assessed in each group. It is expected that the normal control group will reach the requisite level of comprehension faster than the schizophrenia group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DVD patient high risk
Patients with a diagnosis of schizophrenia/schizoaffective disorder randomized to the DVD, high risk version
DVD Consent
Participants are randomized to DVD enhanced consent that is either high risk or low risk.
DVD patient low risk
Patient with a diagnosis of schizophrenia/schizoaffective disorder randomized to DVD consent, low risk version
DVD Consent
Participants are randomized to DVD enhanced consent that is either high risk or low risk.
DVD normal high risk
Participants with no psychiatric diagnosis randomized to DVD consent, high risk version
DVD Consent
Participants are randomized to DVD enhanced consent that is either high risk or low risk.
DVD normal low risk
Participants with no psychiatric diagnosis randomized to DVD consent, low risk version
DVD Consent
Participants are randomized to DVD enhanced consent that is either high risk or low risk.
Routine control high risk
Participants with no psychiatric diagnosis randomized to routine consent, high risk version
Routine Control
Participants are assigned to the routine, standard consent.
Routine control low risk
Participants with no psychiatric diagnosis randomized to routine consent, low risk version
Routine Control
Participants are assigned to the routine, standard consent.
Routine patient low risk
Participants with schizophrenia/schizoaffective disorder randomized to routine consent, low risk version
Routine Control
Participants are assigned to the routine, standard consent.
Routine patient high risk
Participants with schizophrenia/schizoaffective disorder randomized to routine consent, high risk version
DVD Consent
Participants are randomized to DVD enhanced consent that is either high risk or low risk.
Routine Control
Participants are assigned to the routine, standard consent.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DVD Consent
Participants are randomized to DVD enhanced consent that is either high risk or low risk.
Routine Control
Participants are assigned to the routine, standard consent.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fluency in English
* Written informed consent
Exclusion Criteria
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
University of California, San Diego
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dilip V. Jeste
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dilip V. Jeste, MD
Role: PRINCIPAL_INVESTIGATOR
UCSD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, San Diego
San Diego, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.